Skip to content

20-007 - Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

Status: open

A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

Treatment for Parkinson's Disease

Contact Us Or call (251) 445-9834

Description

Parkinson's Disease clinical trial testing a new compound of carbidopa/levodopa that is delivered by a 24 continuous infusion. Previous studies with this new drug have been promising and the purpose of this study is to assess the efficacy, safety, and the tolerability of the drug. Study activities include neurological and physical exams, questionnaire, physical function tests, blood tests.

Sponsors

This trial is sponsored by AbbVie.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

    This link will open in a new tab or window.